Car T-Cell Therapy
VIDEO: Updates in immune, cellular therapies in acute myeloid leukemia
In this video, Naval Daver, MD, discusses a presentation on updates in immune and cellular therapy in acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.
Novel technique may provide ‘incredible’ benefit to CAR T-cell therapy
A novel therapeutic approach may improve the persistence and functionality of chimeric antigen receptor T cells, helping to prevent relapse.
‘We are a team’: ACR highlights self-management for Rheumatic Disease Awareness Month
Every September, a national spotlight shines on rheumatic diseases, a wide-ranging group of more than 100 different conditions that shape the lives of millions of people every day.
CCR West turns 40 with ‘cutting-edge’ data on CAR T cells, precision medicine
Chimeric antigen receptor T-cell therapy and precision medicine will highlight the agenda at the 40th annual Congress of Clinical Rheumatology West, set for Sept. 26 to Sept. 29 in San Diego, California.
FDA fast tracks CAR T-cell therapy for refractory lupus in anticipation of phase 1 trial
The FDA has granted fast track designation to CB-010, an allogeneic anti-CD19 CAR T-cell therapy from Caribou Biosciences, for refractory systemic lupus erythematosus ahead of a planned phase 1 trial, according to a press release.
FDA approves IND application for Eque-cel T-cell therapy in SLE, lupus nephritis
The FDA has approved an investigational new drug application for Eque-cel, an autologous T-cell injection, in patients with systemic lupus erythematosus and lupus nephritis, according to a press release from the manufacturer.
Growing armamentarium means ‘we have options’ for ANCA-associated vasculitis
An growing therapeutic armamentarium for antineutrophil cytoplasmic antibody-associated vasculitis — including avacopan and azathioprine — is providing rheumatologists with an increasingly robust array of options, according to a presenter.
Early findings suggest CAR-T for solid tumors may advance beyond ‘very nascent stage’
It’s only the beginning.
VIDEO: CAR T-cell therapy ‘holding up as a possible breakthrough’ in autoimmune disease
In this video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, calls out top stories in the July issue, including a cover story on chimeric antigen receptor T-cell therapy.
CAR T cells one year later: What have we learned?
Nearly 1 year ago, I wrote my first editorial about the emergence and excitement surrounding the early experience with CAR T cells — CAR T Cells in Autoimmunity: A Potential Therapy About to Explode.